Rapport Therapeutics, Inc.
RAPP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002012593
In the last 90 days, Rapport Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 160 institutions reported holding it in 13F filings for Q2 2026, worth $2.13B in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Rapport Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 124
- +42 vs. Q2 2025
- Shares held
- 49.3M
- +10.8M (+28.0%) vs. Q2 2025
- Total value
- $1.46B
- +$1.03B (+234.2%) vs. Q2 2025
- New holders
- 51
- 37 more added
- Sold out
- 9
- 20 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RAPP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 160 | $2.13B |
| Q1 2026 | 147 | $1.64B |
| Q4 2025 | 144 | $1.55B |
| Q3 2025 | 124 | $1.46B |
| Q2 2025 | 82 | $437.9M |
| Q1 2025 | 77 | $382.3M |
| Q4 2024 | 70 | $648.9M |
| Q3 2024 | 55 | $581.9M |
| Q2 2024 | 35 | $593.4M |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Rapport Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| State Street Corp | 371,626 | $11.0M | 0.00% | +72,918+24.4% | Added |
| Perceptive Advisors LLC | 403,923 | $12.0M | 0.35% | +403,923 | New |
| Adage Capital Partners GP, L.L.C. | 450,000 | $13.4M | 0.02% | +450,000 | New |
| Geode Capital Management, LLC | 533,403 | $15.8M | 0.00% | +200,244+60.1% | Added |
| UBS Group AG | 558,073 | $16.6M | 0.00% | +284,566+104.0% | Added |
| T. Rowe Price Investment Management, Inc. | 707,508 | $21.0M | 0.01% | +93,689+15.3% | Added |
| Alliancebernstein L.P. | 855,620 | $25.4M | 0.01% | −299,068−25.9% | Reduced |
| UBS Asset Management Americas Inc | 892,258 | $26.5M | 0.01% | +648,378+265.9% | Added |
| Polar Capital Holdings Plc | 938,952 | $27.9M | 0.13% | +938,952 | New |
| Vestal Point Capital, LP | 950,000 | $28.2M | 1.28% | +950,000 | New |
| TRV GP VI, LLC | 969,218 | $28.8M | 26.26% | 00.0% | Unchanged |
| Siren, L.L.C. | 1,053,469 | $31.3M | 1.22% | +675,000+178.4% | Added |
| Price T Rowe Associates Inc | 1,102,391 | $32.7M | 0.00% | −423,128−27.7% | Reduced |
| Baker Bros. Advisors LP | 1,547,090 | $45.9M | 0.33% | +997,000+181.2% | Added |
| BlackRock, Inc. | 1,568,081 | $46.6M | 0.00% | +348,880+28.6% | Added |
| Vanguard Group Inc | 1,626,538 | $48.3M | 0.00% | +519,047+46.9% | Added |
| Johnson & Johnson | 1,784,517 | $53.0M | 10.52% | −713,534−28.6% | Reduced |
| Sofinnova Investments, Inc. | 1,947,579 | $57.8M | 3.55% | −48,015−2.4% | Reduced |
| Goldman Sachs Group Inc | 2,421,976 | $71.9M | 0.01% | +1,186,941+96.1% | Added |
| Cormorant Asset Management, LP | 3,192,521 | $94.8M | 6.54% | +251,600+8.6% | Added |
| Capital International Investors | 3,402,529 | $101.1M | 0.02% | +800,000+30.7% | Added |
| ARCH Venture Management, LLC | 3,728,738 | $110.7M | 22.49% | 00.0% | Unchanged |
| FMR LLC | 6,916,995 | $205.4M | 0.01% | +1,442,362+26.3% | Added |
| TRV GP V, LLC | 7,135,233 | $211.9M | 59.95% | 00.0% | Unchanged |
| Logos Global Management LP | 0 | $0 | 0.00% | −208,910−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −199,643−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −185,028−100.0% | Sold out |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −131,340−100.0% | Sold out |
| Deep Track Capital, LP | 0 | $0 | 0.00% | −98,237−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Intech Investment Management LLC | 0 | $0 | 0.00% | −11,462−100.0% | Sold out |
| Kennedy Capital Management, Inc. | 0 | $0 | 0.00% | −11,230−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |